On the mechanism of antiatherosclerotic agents: microchemical studies on the in vitro effects of pyridinol carbamate and estrogen (premarin) on phosphofructokinase and malate dehydrogenase in the arterial wall.
D002219:Carbamates; D002463:Cell Membrane Permeability / Q000187:drug effects; D002648:Child; D002849:Chromatography, Gas; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000378:metabolism; D004966:Estrogens, Conjugated (USP) / Q000097:blood / Q000494:pharmacology*; D005260:Female; D005263:Femoral Artery / Q000187:drug effects* / Q000201:enzymology; D005470:Fluorometry; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D008291:Malate Dehydrogenase / Q000378:metabolism*; D013058:Mass Spectrometry; D008722:Methods; D010732:Phosphofructokinase-1 / Q000378:metabolism*; D011727:Pyridinolcarbamate / Q000097:blood / Q000494:pharmacology; D013268:Stimulation, Chemical
D002219:Carbamates; D004966:Estrogens, Conjugated (USP); D000960:Hypolipidemic Agents; D004958:Estradiol; D011727:Pyridinolcarbamate; D008291:Malate Dehydrogenase; D010732:Phosphofructokinase-1